Health technology assessment, a multidisciplinary process designed to evaluate the social, economic, organizational, and ethical issues of a health intervention or health technology, has long been dominated by cost-effectiveness metrics. These metrics predominantly focus on maximizing health outcomes per unit of cost, often neglecting how benefits and burdens are distributed across different social groups. The commentary posits that this focus inadequately captures the complexities of health inequities prevalent in LMICs, where socioeconomic disparities and historical injustices severely affect health access and outcomes. By sidelining equity, traditional HTAs risk inadvertently perpetuating systemic health disparities.

The authors underscore South Africa as a poignant case study, given its stark socio-economic gradients and a legacy deeply imprinted by apartheid-era inequalities. This context illustrates vividly how cost-effectiveness-driven decisions can fall short when applied to heterogeneous populations with divergent health risks and access profiles. In countries like South Africa, health technologies or interventions that appear cost-effective on average may, in practice, exacerbate inequities by privileging already advantaged groups. Thus, the need arises for HTAs that are sensitive to equity concerns and capable of informing policies that promote both efficiency and fairness.

One of the central technical challenges addressed is the operationalization of equity within HTA frameworks. Equity, as a normative concept, is multifaceted—encompassing dimensions such as socioeconomic status, geographic location, gender, ethnicity, and disability. Integrating these into quantitative models requires metrics that reflect distributional impacts rather than aggregate benefits alone. Siriram and Harris advocate for incorporating equity weights in decision analytic models to better capture trade-offs between efficiency and fairness. These weights adjust the value attributed to health gains depending on who benefits, prioritizing disadvantaged populations where necessary.

The commentary further critiques the prevalence of utilitarian approaches that dominate global HTA practices. Utilitarianism, with its focus on aggregate utility maximization, may overlook concerns around fairness and justice, which are central to equitable healthcare provision. The authors argue for a pluralistic ethical framework in HTA processes that can reconcile efficiency with equity. This calls for methodologies that incorporate stakeholder engagement and deliberative processes, ensuring that diverse societal values inform health priority setting.

Data limitations present another formidable obstacle in adequately addressing equity. In many LMICs, robust disaggregated data on health outcomes and determinants are scarce or incomplete. This gap constrains the ability of modelers to reliably estimate how interventions affect different social strata. Siriram and Harris emphasize the need for investments in health information systems that capture granular equity-relevant data. Enhanced data capabilities enable more precise modeling of the differential impacts of technologies among subpopulations, thereby improving the evidence base for equitable policymaking.

A critical dimension of this equity-focused HTA adaptation concerns the integration of social determinants of health. Factors such as education, housing, nutrition, and employment significantly influence health outcomes, yet traditional HTA models seldom account for these complexities. The commentary advocates for interdisciplinary approaches that blend clinical outcomes with social science insights, enabling a more holistic assessment of intervention impacts beyond the health sector. Such incorporation is vital for addressing root causes of disparities rather than merely managing their clinical manifestations.

Policy implications of shifting HTA paradigms towards equity are profound. Allocating healthcare resources with an equity lens may require sacrificing some aggregate health gains to improve outcomes in marginalized groups. This deliberate trade-off challenges policymakers and health economists who are accustomed to efficiency-driven metrics. However, the authors argue convincingly that sustainable health improvements in LMICs hinge on inclusive approaches that rectify entrenched inequities rather than perpetuate them under the guise of cost-effectiveness.

Siriram and Harris also discuss the practicality of implementing equity-inclusive HTAs in LMIC settings. They caution that resource constraints and capacity limitations complicate the adoption of more complex assessment frameworks. Nonetheless, they highlight innovative approaches emerging from South Africa and other LMICs where local adaptations of HTA methodologies incorporate equity considerations within existing institutional contexts. These case examples demonstrate that with political will and stakeholder engagement, it is feasible to embed equity into HTA processes even where resources are limited.

The commentary further addresses the global health governance landscape and the role of international organizations in promoting equity-oriented HTA practices. It calls on entities such as the World Health Organization and development partners to support capacity-building and knowledge sharing that prioritize equitable evaluation frameworks. Such support is essential to harmonize efforts across countries and prevent the marginalization of equity perspectives in global policy dialogues dominated by economic efficiency narratives.

Siriram and Harris also touch on the ethical imperative of equity in health technologies during pandemics and public health emergencies. The COVID-19 pandemic exposed widespread disparities in access to vaccines and therapeutics, highlighting the limitations of conventional HTA processes under crisis conditions. Incorporating equity considerations into emergency health technology assessments can guide more just and effective resource allocation when time and stakes are high.

Moreover, the authors stress that equity-adapted HTAs must remain context-specific, tailored to the unique social, cultural, and epidemiological realities of each country. This implies that standardized global guidelines need flexible frameworks accommodating local priority settings and equity notions. Successful integration of equity into HTA is not a one-size-fits-all endeavor but a nuanced process guided by local expertise and inclusive consultation.

Finally, the article ends on a visionary note, calling on researchers, policymakers, and practitioners to co-create the next generation of HTA methodologies with equity at their core. By moving beyond the narrow confines of cost-effectiveness, health technology assessments in LMICs can become powerful tools for social justice, ultimately contributing to healthier, fairer societies. This transformative agenda resonates strongly in an era where the global health community increasingly recognizes that efficiency divorced from equity risks deepening rather than closing gaps in health outcomes worldwide.

Subject of Research:
Adapting global health technology assessment frameworks to integrate equity considerations in low- and middle-income countries, focusing on the South African context.

Article Title:
Beyond cost-effectiveness: a reflective commentary on adapting global health technology assessment for equity considerations in South Africa and other LMICs.

Article References:
Siriram, C., Harris, R. Beyond cost-effectiveness: a reflective commentary on adapting global health technology assessment for equity considerations in South Africa and other LMICs. Int J Equity Health 24, 316 (2025). https://doi.org/10.1186/s12939-025-02676-z

Image Credits: AI Generated

DOI: https://doi.org/10.1186/s12939-025-02676-z

Traditional cost-effectiveness analysis (CEA) has long served as a cornerstone in health economics, enabling policymakers to compare the financial inputs and health outcomes associated with various interventions. However, conventional CEA predominantly focuses on average effectiveness metrics, often overlooking the critical dimension of how benefits and costs are distributed across socioeconomic or demographic subpopulations. This limitation constrains its utility in informing policies aimed at reducing health inequities. The ADC-CEA framework directly addresses this gap by integrating distributional considerations into the core of economic evaluations, offering a panoramic view of both cost-effectiveness and equity.

At the heart of ADC-CEA lies the integration of aggregate measures of health outcomes alongside detailed distributional data, allowing for a simultaneous assessment of total health benefits and their dispersion. Unlike traditional models that treat the population as a monolith, this approach meticulously disaggregates data to capture the heterogeneity of health gains. By modeling how interventions affect various subgroups—distinguished by factors such as income, geography, or baseline health status—the framework facilitates a more granular and ethically informed evaluation. This is especially pivotal in settings where health inequalities are stark and persistent.

The research team employed advanced statistical and mathematical modeling techniques to construct the ADC-CEA tool. These methods enable analysts to move beyond mean outcomes and quantify inequality-weighted health benefits. The technique incorporates parameters reflecting societal preferences regarding equity, which can be flexibly adjusted to reflect different policy priorities. Consequently, decision-makers can explore trade-offs between maximizing efficiency (i.e., overall health gains) and promoting fairness. This methodological versatility empowers stakeholders to align resource allocation strategies with both economic rationality and ethical values.

One of the most compelling applications of ADC-CEA is its utility in global health contexts marked by diverse burden distributions and resource constraints. Low- and middle-income countries frequently grapple with the challenge of addressing pressing health needs while confronting limited budgets. Here, a nuanced understanding of how interventions influence health disparities is crucial. By using ADC-CEA, health ministries and international organizations can identify interventions that not only deliver high aggregate health returns but also meaningfully reduce inequities. This dual focus enhances the social legitimacy and sustainability of health programs.

The implications of integrating distributional analysis extend to policy debates around universal health coverage and priority setting. Traditionally, policymakers face ethical dilemmas when confronted with choices that benefit certain groups disproportionately. ADC-CEA equips them with robust quantitative evidence to navigate these conflicts judiciously. For example, the model can reveal whether an intervention favors marginalized populations enough to justify a slightly lower overall health gain, thereby embedding fairness into objective decision frameworks. This paradigm shift could spur more equitable healthcare systems globally.

The authors also highlight the role of ADC-CEA in fostering transparency and public trust in health economic evaluations. By explicitly characterizing who gains and who loses from health investments, the tool makes the often opaque process of resource allocation more comprehensible and accountable. Stakeholders, including the general public, patient advocacy groups, and clinicians, may better engage in deliberations informed by accessible distributional data. Such inclusivity is vital for democratic health governance and the ethical stewardship of public funds.

Technically, the ADC-CEA model advances beyond prior distribution-sensitive methods by scaling aggregate and distributional outputs within a unified analytic framework. This harmonization addresses previous computational and interpretive challenges faced by researchers attempting to integrate equity concerns. The framework’s modular design allows for the inclusion of varied health metrics, ranging from quality-adjusted life years (QALYs) to disability-adjusted life years (DALYs), enhancing its applicability across diverse health domains. This flexibility underscores the framework’s potential to become a new standard in economic evaluations.

In evaluating the feasibility of ADC-CEA, the researchers conducted extensive simulations and real-world case studies. These exercises demonstrated that the framework could be successfully operationalized using routinely collected health data, a critical factor for widespread adoption. Moreover, sensitivity analyses confirmed the robustness of results under various societal preference configurations, lending credibility to the method’s reliability and adaptability. Such empirical validation is essential for convincing policymakers and funding agencies to incorporate ADC-CEA into their decision-making processes.

Interestingly, the methodological innovation also opens avenues for integrating behavioral economics insights into health policy evaluation. By incorporating societal preferences related to equity, the framework implicitly acknowledges that economic decisions are value-laden and influenced by ethical judgments. This alignment with behavioral perspectives promotes a more holistic understanding of healthcare priorities, transcending strict utilitarianism. As a result, ADC-CEA can serve as a platform for interdisciplinary collaboration bridging economics, ethics, and public health.

The timing of this development is particularly salient amid global efforts to recover from the COVID-19 pandemic, which has exacerbated health disparities across and within nations. Policymakers now face amplified demands to allocate resources efficiently yet equitably to rebuild resilient health systems. The ADC-CEA framework offers a scientifically grounded tool tailored for such contexts, where trade-offs between economic constraints and social justice are pronounced. By applying this approach, health authorities can design pandemic responses and recovery plans that explicitly target the most vulnerable populations while maximizing overall benefits.

Furthermore, the proposed tool has implications for implementation science by providing a more complete picture of intervention impacts during scaling-up efforts. Trials and pilot programs may identify effective health innovations, but without distributional insights, scaling decisions risk widening inequities. ADC-CEA ensures that evidence synthesis accounts for both effectiveness and fairness, thus guiding policymakers toward interventions that harmonize these objectives. This enhanced evaluative capacity could significantly influence the trajectory of health innovations in diverse settings.

Despite its promise, the authors acknowledge challenges in adopting ADC-CEA, including the need for high-quality disaggregated data and the complexity of modeling equity preferences accurately. Data limitations and computational demands could pose barriers, particularly in resource-poor environments. However, ongoing advances in health information systems, data analytics, and stakeholder engagement may help overcome these hurdles. The researchers emphasize that building institutional capacity and fostering interdisciplinary collaboration are key to translating this conceptual breakthrough into practical policy impact.

Looking ahead, Jiang and colleagues envision the ADC-CEA framework evolving through integration with machine learning and artificial intelligence techniques, enabling real-time and predictive analyses. Such advancements would elevate health economic evaluation to unprecedented levels of precision and responsiveness. Continuous refinement and empirical testing across varied health domains and geographical contexts will be crucial for refining model parameters and embedding equity considerations into everyday policy decisions worldwide.

In summary, the advent of Aggregate Distributional Cost-Effectiveness Analysis marks a defining moment in health economic evaluation. By reconciling the pursuit of efficiency with the imperative of equity, this tool equips decision-makers with a rich analytical lens to navigate the ethical complexities of resource allocation. Its methodological rigor, coupled with practical applicability, positions ADC-CEA as a catalyst for more just and effective health systems globally. As health inequities remain a profound challenge, such innovations offer a beacon of hope for policy frameworks that honor both science and social justice in improving population health outcomes.

—

Subject of Research: Health economic evaluation methodologies incorporating equity to improve resource allocation decisions in healthcare.

Article Title: Aggregate distributional cost-effectiveness analysis: a novel tool for health economic evaluation to inform resource allocation.

Article References:

Jiang, S., Li, B., Parkinson, B. et al. Aggregate distributional cost-effectiveness analysis: a novel tool for health economic evaluation to inform resource allocation.
glob health res policy 10, 17 (2025). https://doi.org/10.1186/s41256-025-00415-z

Image Credits: AI Generated